|
|
Article: OMNARIS(TM) Nasal Spray Now Available by Prescription for Patients with Seasonal and Perennial Allergies.
- Article from:
- Business Wire
- Article date:
- April 17, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
* Allergic rhinitis is the most common allergic disease in the U.S., affecting approximately 40 million people, specifically 10 to 30 percent of adults and up to 40 percent of children(1)
* OMNARIS Nasal Spray is currently the only corticosteroid nasal spray designed as a prodrug that is activated after nasal administration and formulated in a novel hypotonic suspension
* The U.S. market for nasal corticosteroids is estimated at approximately $2.3 billion(2)
MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that OMNARIS([TM]) (ciclesonide) Nasal Spray is now available by prescription in pharmacies nationwide. OMNARIS Nasal Spray ...